Multi-dimensional evaluation of dupilumab efficacy in atopic dermatitis patients with a high disease burden

Ital J Dermatol Venerol. 2024 Feb;159(1):63-64. doi: 10.23736/S2784-8671.23.07644-2.

Maria C Fargnoli^{1

2}, Paolo Amerio³, Carlotta Galeone^{4

5}, Elena Nicoli⁶, Maria P Pedone⁶

¹ Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy - mariaconcetta.fargnoli@univaq.it.
² UOSD General and Oncologic Dermatology, San Salvatore Hospital, L'Aquila, Italy - mariaconcetta.fargnoli@univaq.it.
³ Department of Medicine and Ageing Sciences, G. D'Annunzio University, Chieti, Italy.
⁴ Bicocca Applied Statistics Center (B-ASC), University of Milano-Bicocca, Milan, Italy.
⁵ Unit of Statinfo, Biostatistics and Outcome Research, Statinfo, Milan, Italy.
⁶ Sanofi S.r.l., Milan, Italy.

No abstract available

MeSH terms